13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Diving into the venture builder model: Unpacking the value proposition in nurturing biotech assets

Edition

Diving into the venture builder model: Unpacking the value proposition in nurturing biotech assets

The venture builder or start-up studio model has gained prominence in nurturing early-stage biotech assets, offering a unique approach to supporting innovation. What distinguishes them from more traditional incubators and accelerators? Is there really a single start-up studio model? How do they collaborate with academic institutions, research organisations, and industry partners? How do venture builders effectively add value to early-stage biotech companies and has this proven effective? What are the challenges and limitations of the model?

Moderator: Gerald Law, Chief Executive, Innovation DB 

Kåre Engkilde

Entrepreneur in Residence
Denmark
BioInnovation Institute

William Hariri

Co-founder & CBO
United Kingdom
Exert Therapeutics

Clément Bertholet

Partner
France
AdBio Partners
Scroll to Top
  • No products in the cart.